Impatient Ventures

The firm's name signals a deliberate departure from the patient, multi-year incubation model common in early-stage venture. Impatient Ventures pursues a high-velocity investment posture, prioritizing rapid commercial traction and compressed timelines between diligence and deployment. This thesis suggests a focus on founders and products that can achieve market validation quickly rather than capital-intensive, long-gestation businesses.

No. Impatient Ventures has not publicly disclosed its assets under management or the size of any specific fund vehicle. The firm's limited public footprint — no LinkedIn presence, minimal website detail, and no SEC filings referencing fund size — is consistent with a small, network-raised venture firm that does not market broadly to institutional limited partners.

The firm focuses on seed and start-up stage companies, the earliest institutional entry points in a company's lifecycle. This typically involves providing initial capital for product development and early go-to-market efforts. The firm's accelerated investment posture suggests a preference for companies that can demonstrate early commercial signals rather than pre-revenue science or deep-tech projects requiring extended R&D horizons.

Impatient Ventures has not publicly identified its founders, managing partners, or investment committee members. No individual names appear in the firm's web presence or in accessible business registrations. This lack of attribution is atypical for a venture firm seeking to attract founders and co-investors, and likely reflects a strategy of operating quietly within a closed network.

The firm's deal sourcing model is not publicly documented. Given its limited web presence and absence of LinkedIn activity, Impatient Ventures likely relies on founder relationships and personal networks within the Los Angeles technology and start-up ecosystem rather than public-facing content marketing or cold inbound founder applications.